Both TNF-α and IL-6 have been associated with obesity and insulin resistance and can alter insulin sensitivity by prompting different phases in the insulin signaling pathway, stimulating hepatic lipogenesis, and impairing insulin signaling (14, 15). Here, INS is linked to obesity disorder.